Abbott Laboratories (ABT)
106.80
-0.09
(-0.08%)
USD |
NYSE |
Apr 25, 13:37
Abbott Laboratories Profit Margin (Quarterly): 12.29% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 12.29% |
December 31, 2023 | 15.56% |
September 30, 2023 | 14.16% |
June 30, 2023 | 13.78% |
March 31, 2023 | 13.52% |
December 31, 2022 | 10.24% |
September 30, 2022 | 13.78% |
June 30, 2022 | 17.93% |
March 31, 2022 | 20.57% |
December 31, 2021 | 17.34% |
September 30, 2021 | 19.22% |
June 30, 2021 | 11.63% |
March 31, 2021 | 17.15% |
December 31, 2020 | 20.20% |
September 30, 2020 | 13.92% |
June 30, 2020 | 7.33% |
March 31, 2020 | 7.30% |
December 31, 2019 | 12.62% |
September 30, 2019 | 11.89% |
June 30, 2019 | 12.61% |
March 31, 2019 | 8.92% |
December 31, 2018 | 8.42% |
September 30, 2018 | 7.35% |
June 30, 2018 | 9.44% |
March 31, 2018 | 5.66% |
Date | Value |
---|---|
December 31, 2017 | -10.91% |
September 30, 2017 | 8.83% |
June 30, 2017 | 4.26% |
March 31, 2017 | 6.61% |
December 31, 2016 | 14.96% |
September 30, 2016 | -6.21% |
June 30, 2016 | 11.53% |
March 31, 2016 | 6.47% |
December 31, 2015 | 14.78% |
September 30, 2015 | 11.26% |
June 30, 2015 | 15.16% |
March 31, 2015 | 46.80% |
December 31, 2014 | 16.88% |
September 30, 2014 | 10.59% |
June 30, 2014 | 9.21% |
March 31, 2014 | 7.89% |
December 31, 2013 | 11.75% |
September 30, 2013 | 20.02% |
June 30, 2013 | 8.74% |
March 31, 2013 | 10.12% |
December 31, 2012 | 33.04% |
September 30, 2012 | 36.90% |
June 30, 2012 | 32.46% |
March 31, 2012 | 23.51% |
December 31, 2011 | -22.90% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
7.30%
Minimum
Mar 2020
20.57%
Maximum
Mar 2022
14.15%
Average
13.78%
Median
Profit Margin (Quarterly) Benchmarks
Boston Scientific Corp | 13.56% |
Stryker Corp | 19.66% |
Intuitive Surgical Inc | 28.82% |
Insulet Corp | 20.26% |
Edwards Lifesciences Corp | 24.11% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | 15.22% |
Return on Assets | 7.70% |
Return on Invested Capital | 10.47% |
Gross Profit Margin (Quarterly) | 55.21% |
Operating Margin (Quarterly) | 13.91% |
Return on Net Operating Assets | 9.76% |